Header Leaderboard Ad

Collapse

{Discussion}Roche stop supporting the 454 platform by mid-2016

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • {Discussion}Roche stop supporting the 454 platform by mid-2016

    Hi, I am a graduate student and I have just heard Roche stop supporting the 454 pyrosequencing platform by 2016. Our university has to buy another Next-gen sequencing platform.

    I was surprised. Does anyone know what happened? Two year ago, I think 454 pyrosequencing occupied >50% market. I don't think this is about business. Also, lots of publications use pyrosequencing

    Are they gonna develop new sequencing technologies? Is pyrosequencing a technological dead end? Is Illumina a good choice?

    Ben

  • #2
    Why is any technology killed off? It's been superseded - either on price or performance or both.

    According to Genomeweb, Illumina had 66% of the market in 2012:

    Illumina currently holds around 66 percent of the total sequencing market, but the company's share of the desktop market is split evenly with Life Technologies' Ion Torrent PGM, according to a recent survey of 150 In Sequence readers.


    Roche's share was 8% at this point.

    I think you may have been a bit misled on their market penetration post PGM and post-MiSeq

    Comment

    Latest Articles

    Collapse

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by seqadmin, 05-26-2023, 09:22 AM
    0 responses
    8 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 05-24-2023, 09:49 AM
    0 responses
    12 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 05-23-2023, 07:14 AM
    0 responses
    30 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 05-18-2023, 11:36 AM
    0 responses
    115 views
    0 likes
    Last Post seqadmin  
    Working...
    X